Key result
QT-prolonging risk factors were highly prevalent in coronary care units, with 74.9% of patients using ≥1 QT-prolonging drugs and interactions associated with female gender.
Cross-Sectional (n=649)
Yes
Answers are grounded in this paper and cite their sources.
There is a high prevalence of QT prolonging risk factors and drug-drug interactions among patients in coronary care units, which is significantly associated with female gender and polypharmacy.
OBJECTIVES: Patients admitted in coronary care units are susceptible to QT interval prolongation due to numerous risk factors. The purpose of this study was to identify the prevalence of risk factors for QT interval prolongation; QT prolonging medications; drug-drug interactions; their predictors; and torsades de pointes risks of drugs. METHODS: After obtaining approval, this cross-sectional study was carried out during one-year period in coronary care units of two major tertiary care hospitals of Khyber Pakhtunkhwa, Pakistan. The Arizona Center for Education and Research on Therapeutics QT drugs lists and Micromedex DrugReax® were used to identify the QT prolonging medications and QT prolonging drug-drug interactions. RESULTS: Total 649 patients were included in this study. The most frequent QT prolonging risk factors included use of ≥ 1 QT prolonging drugs (74.9%) and myocardial infarction (61.3%). Total 181 patients were presented with 361 QT prolonging drug-drug interactions. There was significant association of the occurrence of QT prolonging drug-drug interactions with female gender (p = 0.01), 9-10 prescribed medications (p = 0.001), and > 10 prescribed medications (p < 0.001). CONCLUSIONS: The majority of patients presented with multiple risk factors for QT prolongation in coronary care units which may precipitate lethal outcomes.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2018) conducted a cross-sectional in Patients admitted in coronary care units (n=649). QT prolonging medications and drug-drug interactions was evaluated on Prevalence of risk factors for QT interval prolongation (use of ≥ 1 QT prolonging drugs). QT-prolonging risk factors were highly prevalent in coronary care units, with 74.9% of patients using ≥1 QT-prolonging drugs and interactions associated with female gender.
Synapse has enriched 10 related papers. Consider them for comparative context: